6Moll GW,Patel BR.Pediatric Graves' disease:therapeutic options and experience with radioiodine at the University of Mississippi Medical Center[J].South Med J,1997,90(10):1017-1022.
7Read CH Jr,Tansey MJ,Menda Y.A 36-year Retrospective Analysis of the Efficacy and Safety of Radioactive iodine in Treating Young Grave's Patients.J Clin Endocrinol[J].Metab,2004,89(9):4229-4233.
8Rivkees SA,Sklar C,Freemark M.The management of Graves' disease in children,with special emphasis on radioiodine treatment[J].J Clin Endocrinol Metab,1998,83(11):3767-3776.
9Bahn Rs,Dutten CM,Natt N,et al.Thyrotropin receptor experssion in Graves,orbital adipose connective tissue,potential cell to a antigen in Graves' opthalmopathy[J].J of Clinical Enclocrinology and Metabolism,1998,83(3):998.
10Kenneth D,Burman MD,Ray Pandian Ph D.Clinical unity of assays for TSH Receptor antobodies[J].The Endocrinologist,1998,8(4):284.
2Tsuboi K,Ueshiba H,Shimojo M,et al.The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves'disease.Endocrine J,2007,54:39-43.
5Gianoukakis AG,Leigh MJ,Richards P,et al.Characterization of the anaemia associated with Graves' disease.Clin Endocrinol(Oxf),2009,70:781-787.
6Simchen C,Lihmann I,Sittig D,et al.Expression and regulation of regulated on activation,normal T cells expressed and secreted in thyroid tissue of patients with Graves' disease and thyroid autonomy and in thyroid derived cell populations.J Clin Endocrinol Metab,2000,85:4758-4764.
7Laurberg P,Bulow Pedersen I,Knudsen N,et al.Environ-mental iodine intake affects the type of nonmalignant thyroid disease.Thyroid,2001,11:457-469.
8Tamai H,Sudo T,Kimura A,et al.Association between the DR.B1 ×08032 Histocompatiblity.Antigen and methimazol-induced agranulocytosis in Japanese patients with Graves Disease.Amn Intern Med,1996,124:490-494.
